What pharmacy-made means
Medicine review in the US is the responsibility of the Food and Drug Administration (FDA).
A brand medicine’s approved copy is called a generic; a compounded preparation belongs to a different category.
A semaglutide generic had not received final FDA approval for US sales as of September 26, 2026.
The shortage route changed
After the national shortage ended, FDA gave pharmacies and other medicine makers time before it would enforce certain rules about copying medicines. This delay covered only rules tied to the shortage. That extra time ended in 2025.
A local pharmacy having no stock does not mean the medicine appears on FDA’s national shortage list.
An individual change needs an individual reason
FDA gives the example of a patient needing a medicine prepared without a dye because of an allergy to that dye.
A lower price alone is not enough for that exception. Ask what change to the medicine would meet your medical need and why the approved product would not.
In FDA’s example, a semaglutide preparation can remain essentially a copy even with an added vitamin; adding that ingredient does not create an automatic exception.
Watch for claims that do too much
Watch for the names semaglutide sodium or semaglutide acetate on medicine paperwork. These are different chemical versions of semaglutide, not the ingredient used in approved products. FDA says it knows of no legal basis for using them in compounded medicines.
The extra word sodium or acetate is the clue. Have both the professional writing your prescription and the pharmacy identify the exact ingredient on offer.
- What exact preparation is being proposed?
- What medical need of mine would an approved product fail to meet?
- Which pharmacy would prepare and send it?
- Can the person writing the prescription explain why this choice meets the current rules?